Skip to main content

Table 3 Comparison of baseline characteristics after PSM in two groups

From: A preoperative prediction model based on Lymphocyte-C-reactive protein ratio predicts postoperative anastomotic leakage in patients with colorectal carcinoma: a retrospective study

Variables

 

Anastomotic leakage

n = 35

Non-anastomotic leakage Statistical values

n = 35

p

Age

(< 60/ ≥ 60)

5/30

7/28

1.867

0.172

Sex

(Male/female)

24/11

25/10

0.068

0.794

BMI (Kg/m2)

 

23.6 ± 2.3

22.9 ± 2.5

0.086

0.700

Smoking

(No/Yes)

28/7

26/9

0.324

0.569

Alcohol

(No/Yes)

30/5

32/3

0.565

0.452

Abdominal operation

(No/Yes)

27/8

27/8

0

 > 0.05

T2DM

(No/Yes)

33/2

31/4

0.729

0.393

Cardiovascular disease

(No/Yes)

34/1

33/2

0.348

0.555

Hypertension

(No/Yes)

25/10

26/9

0.072

0.788

COPD

(No/Yes)

31/4

33/2

0.729

0.393

Hepatitis

(No/Yes)

34/1

34/1

0

 > 0.05

Kidney disease

(No/Yes)

34/1

34/1

0

 > 0.05

Hyperlipidemia

(No/Yes)

35/0

34/1

1.014

0.314

Transfusion history

(No/Yes)

35/0

35/0

0

 > 0.05

Bowel preparation

(No/Yes)

0/35

0/35

0

 > 0.05

Hemoglobin (g/L)

(< 90/ ≥ 90)

15/20

14/21

0.059

0.808

Tumor location

Transverse colon descending, sigmoid colon rectum

2/4/29

0/2/33

2.925

0.232

NRS2002

(< 3/ ≥ 3)

9/26

10/25

0.072

0.788

LCR

(≤ 6000/ > 6000)

32/3

11/24

26.589

 < 0.01

ASA score

(I/II/III/IV)

14/16/5/0

16/16/2/1

2.419

0.490

ECOG score

(0/1/2/3/4)

2/26/7/0

8/20/5/2

6.716

0.082

Total bilirubin (μmol/L)

 

11.1 ± 5.2

13.1 ± 6.7

0.002

0.194

Direct bilirubin (μmol/L)

3.3 ± 1.6

2.7 ± 1.4

0.356

0.127

ALT (IU/L)

 

17.6 ± 10.1

15.5 ± 9.5

0.153

0.364

AST (IU/L)

 

18.0 ± 8.2

18.3 ± 8.5

0.083

0.887

Prealbumin (g/L)

 

0.18 ± 0.05

0.21 ± 0.04

0.057

0.105

Albumin (g/L)

 

37.9 ± 4,0

38.1 ± 4.4

0.461

0.898

Urea (mmol/L)

 

4.77 ± 2.0

5.5 ± 4.0

0.249

0.284

Creatinine (μmol/L)

 

77.9 ± 15.9

87.1 ± 65.9

1.444

0.424

Uric acid (μmol/L)

 

295.0 ± 78.9

289.1 ± 76.3

0.055

0.750

White blood count(109/L)

6.6 ± 2.8

5.7 ± 1.4

5.966

0.080

Neutrophil count (109/L)

4.3 ± 2.7

3.4 ± 1.3

4.565

0.085

Lymphocyte count (109/L)

1.5 ± 0.7

1.5 ± 0.6

0.995

0.989

Hematocrit (%)

 

34.5 ± 5.1

32.6 ± 6.1

1.935

0.145

Platelet count (109/L)

 

208.7 ± 93.4

212.9 ± 77.4

0.047

0.835

APTT(s)

 

32.6 ± 4.5

33.6 ± 4.6

0.154

0.361

PT(s)

 

11.3 ± 0.9

11.3 ± 0.8

1.019

0.937

INR

 

0.99 ± 0.07

0.98 ± 0.07

0.037

0.619

  1. BMI body mass index, ASA American Society of Anesthesiologists, ECOG Eastern Cooperative Oncology Group, COPD Chronic Obstructive Pulmonary Disease, NRS2002 Nutritional Risk Screening 2002, LCR Lymphocyte-C-reactive protein Ratio, ALT alanine aminotransferase, AST aspartate aminotransferase, T2DM type 2 diabetes mellitus, APTT activated partial thromboplasin time, PT prothrombin time, INR international normalized ration